BERLIN—Bayer AG unveiled on Wednesday billions in new costs cuts to offset falling demand in agricultural products—the market on which it had made a huge bet with its acquisition of Monsanto.

The German chemicals and pharmaceuticals company said the coronavirus pandemic would hit its crop-science business harder than anticipated as prices for various crops fell, consumption of biofuel decreased and competition in the soy market intensified.

Bayer,…

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.